Checking leftover COVID virus after recovery
Part of Infections, Lungs & breathing clinical trials.
This study looks for whether small amounts of the COVID virus are still present in the lungs after infection. It may help doctors understand how long the virus can remain and inform future care, using tissue removed during a medically needed lung procedure.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You need a doctor-recommended procedure to remove part of the lung (pulmonary resection).
- You can sign and give informed consent to join the study.
- You do not have an active COVID-19 infection right now.
- You must be able to provide informed consent (not withheld or refused).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects samples from people who currently have, recently had, or may have been exposed to common respiratory viruses. The goal is to use these samples to develop and test future countermeasures (like treatments) against COVID-19 and other viruses.
This study checks how well your lungs work and how much exercise you can do after you’ve been discharged from the hospital for COVID-19. It also measures blood (serology) results to understand recovery and possible immune response changes over time.
This trial studies people with mild to moderate COVID-19 symptoms to better understand and help “post-COVID” condition (ongoing effects after infection). You may be eligible if you’re an adult with a recent confirmed COVID-19 test and you agreed to take part.
This study looks at what factors may make COVID-19 symptoms or infection effects last after someone has recovered. It also collects certain body samples to better understand why this persistence happens.
This study looks for signs of leftover SARS-CoV-2 virus in people who have fully recovered from COVID-19, including those with ongoing neurological symptoms (like brain fog, fatigue, or nerve pain). It aims to understand why some people have long-lasting symptoms after infection.
This study looks at why some people develop long-term lung problems after COVID-19. It compares people who had severe COVID-19 and were hospitalized to those who had mild infections and recovered at home.
Hear when a new Covid19 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.